Personal information

No personal information available

Activities

Collapse all

Works (5)

The Cost of Downstream Adverse Outcomes Associated with Allogeneic Blood Transfusion: A Retrospective Observational Cohort Study

Healthcare
2025-02-26 | Journal article
DOI: 10.3390/healthcare13050503
Contributors: Michelle Roets; David John Sturgess; Kerstin Hildegard Wyssusek; Sung Min Lee; Melinda Margaret Dean; Andre van Zundert
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Intraoperative cell salvage as an alternative to allogeneic blood transfusion: an evaluation of immune related adverse outcomes.

2024-08-19 | Dissertation or Thesis
DOI: 10.14264/3e58604
Source: check_circle
Crossref

Intraoperative cell salvage: The impact on immune cell numbers

PLOS ONE
2023-08-01 | Journal article
DOI: 10.1371/journal.pone.0289177
Contributors: Michelle Roets; Afsheen Raza; David Sturgess; Thu Tran; Maheshi Obeysekera; Alexis Perros; John-Paul Tung; Robert Flower; Andre van Zundert; Melinda Dean
Source: check_circle
Crossref

Intraoperative Cell Salvage as an Alternative to Allogeneic (Donated) Blood Transfusion: A Prospective Observational Evaluation of the Immune Response Profile

Cell Transplantation
2020-01-01 | Journal article
DOI: 10.1177/0963689720966265
Contributors: Michelle Roets; David John Sturgess; Maheshi Prabodani Obeysekera; Thu Vinh Tran; Kerstin Hildegard Wyssusek; Jaisil Eldo Jos Punnasseril; Diana da Silva; Andre van Zundert; Alexis Jacqueline Perros; John Paul Tung et al.
Source: check_circle
Crossref

Intraoperative cell salvage: A technology built upon the failures, fads and fashions of blood transfusion

Anaesthesia and Intensive Care
2019-09 | Journal article
DOI: 10.1177/0310057X19860161
Contributors: Michelle Roets; David J Sturgess; Kerstin Wyssusek; André A van Zundert
Source: check_circle
Crossref

Peer review (2 reviews for 1 publication/grant)

Review activity for Heliyon. (2)
How many people are using ORCID?